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Abstract Bcl-2/adenovirus E1B 19 kDa interacting protein
2-like, BNIP-2-like (BNIPL) is a recently cloned and character-
ized apoptosis-associated protein that shares 72% homology
with BNIP-2. It is highly expressed in human placenta and
lung. A yeast two-hybrid system was used to obtain two
BNIPL-interacting proteins, MIF (macrophage migration inhib-
itory factor) and GFER (growth factor erv1 (Saccharomyces
cerevisiae)-like). The interactions were con¢rmed by glutathione
S-transferase pull-down assay in vitro and co-immunoprecipita-
tion assay in vivo. Colony formation assay and cell proliferation
test suggest that overexpression of BNIPL could inhibit the
growth of BEL-7402 cells. These ¢ndings suggest that BNIPL
may physically bind to cell proliferation-related proteins, MIF
and GFER.
5 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Cell proliferation and apoptosis are the two essential oppo-
site cellular processes [1]. Apoptosis, programmed cell death,
is a regulated process of selective cell deletion while the pro-
liferation is one of the choices for the survival cells [2]. Both
of the processes are physiologically closely associated and
regulated. Their coordination and balance are crucial for gov-
erning both homeostasis and normal development of cells and
tissues. Deregulated cell proliferation and suppressed apopto-
sis constitute the minimal common platform upon which can-
cer and autoimmune diseases occur [3^5]. The signal trans-
duction between the proliferation and cell death has been
recognized with many observations. The mutations promoting
inappropriate entry into cell proliferation often promote apo-
ptosis [1]. The overexpression of anti-apoptotic members of
the Bcl-2 family proteins can suppress proliferation and pro-
mote entry into G0 [6]. Also, the existing experimental data
suggest that there would be a functional relation between the
proliferation and death pathway for preventing the survival
and expansion of clones of aberrant cells [1]. A convincing
example is that a controller of cell proliferation, Myc, was
found to be a powerful inducer of apoptosis [3]. Most re-
cently, the death receptors that are regarded as signal of ap-
optosis conventionally or their downstream regulators are re-
ported to promote cell proliferation [7]. Therefore, it will
become necessary to ¢nd out potential cross linkers.
Bcl-2/adenovirus E1B 19 kDa interacting protein 2-like,
BNIP-2-like (BNIPL) is a recently cloned and characterized
apoptosis-associated protein that shares 72% homology (46%
identity) with BNIP-2. BNIP-2 can interact with the Bcl-2 and
adenovirus E1B 19 kDa protein and has the function of pro-
tecting cells against death induced by viral infection or other
proapoptotic stimuli [8]. It has been reported that BNIPL can
cause apoptosis mediated by an apoptosis-inducing BCH
(BNIP-2 and Cdc42GAP homology) domain [9^11].
We focus on the cell functions of this apoptosis-associated
protein BNIPL. A yeast two-hybrid screening is carried out to
¢nd out the interacting proteins of BNIPL. The e¡ect of
BNIPL on the growth of tumor cells is also investigated.
Here, we report the experimental results that support another
role for BNIPL in the cytoplasm.
2. Materials and methods
2.1. Northern blot analysis
Northern blot analysis was carried out using Human 8-lane MTN
Blot membrane (Clontech) as per manufacturer’s protocol. The
BNIPL (accession no. AF193056) cDNA probe was prepared by the
random primer labeled with 32P using rediprime II random prime
labeling system (Amersham Pharmacia Biotech). After prehybridiza-
tion, hybridization and highly stringent washing, the membrane was
exposed to an X-ray ¢lm at 370‡C.
2.2. Yeast two-hybrid screening
A LexA-based yeast two-hybrid system DupLEX-A (OriGene,
Rockville, MD, USA) was used in library screening. The complete
coding sequence of BNIPL was cloned into the vector pEG202-NLS
containing a DNA-binding domain as the bait. In the screening, the
resulting plasmid and human lung cDNA library fused to activation
domain were sequentially transformed into the yeast strain EGY48
that harbors the LEU2 and lacZ report genes under the control of
LexA binding sites. The total 3U106 transformants were screened for
the positive clones with galatose-dependent lacZþ and LEU2þ phe-
notypes by replica plating on galactose/ra⁄nose media lacking glu-
cose, uracil, histidine and tryptophane in the presence of 5-bromo-4-
chloro-3-indolyl-L-D-galactoside or in absence of leucine. A mating
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test was performed to pluck the speci¢c protein^protein interactions.
The pJG4-5-cDNA constructs were isolated from the positive yeast
clones and sequenced. Homology was searched with the BLAST algo-
rithm through the National Center for Biotechnology Information
web site at http://www.ncbi.nlm.nih.gov.
2.3. Glutathione S-transferase (GST) pull-down assay
The DNAs encoding the entire protein sequences of MIF (macro-
phage migration inhibitory factor) and GFER (growth factor erv1
(Saccharomyces cerevisiae)-like) were cloned into the pGEX-5X-1 vec-
tor (Amersham Pharmacia Biotech) that has GST as fusion partner,
respectively. The GST fusion proteins were expressed in 0.1 mM iso-
propyl-1-thio-L-D-galactopyranoside-induced Escherichia coli strain
BL21 (DE3) and puri¢ed by glutathione^Sepharose 4B beads (Amer-
sham Pharmacia Biotech). The BNIPL was cloned into the vector
pCMV-HA2. The hemagglutinin (HA)^BNIPL fusion protein was
generated by the TNT T7 Quick Coupled Transcription/Translation
System (Promega) and tested by Western blotting with anti-HA anti-
body (Clontech). Equivalent amounts of GST^MIF, GST^GFER and
GST alone immobilized on glutathione^Sepharose 4B beads as well as
5 Wl HA-tagged BNIPL were incubated for 2 h at 4‡C with gentle
shaking in 50 Wl NETN bu¡er consisting of 100 mM NaCl, 1 mM
EDTA, 20 mM Tris^HCl, pH 7.5, 0.5% (v/v) Nonidet P-40, 1 mM
phenylmethylsulfonyl £uoride. The beads were washed three times in
100 Wl bu¡er H with the components of 20 mM HEPES, pH 7.7,
50 mM KCl, 20% (v/v) glycerol, 0.1% (v/v) Nonidet P-40 and
0.007% (v/v) L-mercaptoethanol, and boiled in 20 Wl elution bu¡er.
Proteins in the supernatant were separated by 12% SDS^PAGE. The
separated proteins were transferred to PVDF membrane and immu-
noblotted with rabbit anti-HA (Clontech) primary antibody and
horseradish peroxidase (HRP) conjugated goat anti-rabbit IgG (Cal-
biochem). The HA-tagged protein was visualized with DAB substrate
kit (Roche) for HRP.
2.4. Co-immunoprecipitation assay
COS-7 (monkey kidney) cells were cultivated in 6-well plates to 70%
con£uence and co-transfected with 2 Wg plasmids of HA2^BNIPL
with Myc-tagged MIF and Myc-tagged GFER, respectively. After
48 h of incubation in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (Life Technol-
ogies) under the condition of 5% CO2 at 37‡C, the cells were har-
vested and washed twice with ice-cold PBS and lysed with lysis bu¡er
(supplied in Luciferase Detection Kit, Roche). In each precipitation
reaction, 500 Wl lysate was pre-cleaned with protein A/G PLUS aga-
rose (Santa Cruz Biotechnology) for 1 h at 4‡C with gentle shaking
followed by immunoprecipitation with 200 ng monoclonal anti-HA
antibody (Santa Cruz Biotechnology) at 4‡C overnight. The pellets
were washed with 100 Wl lysis bu¡er three times. The precipitated
proteins were eluted from the beads with protein loading bu¡er,
and separated by 15% SDS^PAGE. Proteins were transferred to
PVDF membrane and immunoblotted with mouse anti-Myc primary
antibody (Invitrogen) and HRP conjugated rabbit anti-mouse IgG.
The immunocomplexes were visualized with SuperSignal West Femto
Maximum sensitivity substrate for HRP (Pierce).
2.5. Colony formation assay
BNIPL-encoding sequence was cloned into the expression vector
pcDNA4-HisMax-TOPO (Invitrogen). The plasmid DNA was ex-
tracted and puri¢ed with the plasmid puri¢cation system (Qiagen).
To follow the procedures recommended by the manufacturer (Life
Technologies), BEL-7402 cells (human epithelial-like hepatoma) culti-
vated in a 6-well plate were transfected with pcDNA4-HisMax/
BNIPL, pcDNA4-HisMax/p53 and pcDNA4-HisMax void vector by
means of LipofectAMINE, respectively. The transfected cells were
incubated for 14 days under the condition of 5% CO2 at 37‡C in
DMEM supplemented with 10% fetal bovine serum (Life Technolo-
gies) and 200 Wg/ml zeocin. The colonies were examined with an in-
verted microscope and assigned scores. This kind of experiment was
repeated three times.
2.6. E¡ect of BNIPL on the proliferation of BEL-7402 cells
BEL-7402 cells were cultivated on four 96-well plates with 1U104
cells per well. Under the experimental conditions recommended
by manuacturer (Life Technologies), these cells were transfected
with plasmids pcDNA4-HisMax/BNIPL, pcDNA4-HisMax/p53 and
pcDNA4-HisMax void vector by means of LipofectAMINE, respec-
tively. The transfected cells were supplied with DMEM supplemented
with 10% fetal bovine serum (Life Technologies) and 200 Wg/ml zeo-
cin, and incubated under the condition of 5% CO2 at 37‡C for 1 week.
The cells were counted every 24 h to detect the proliferation of cells in
the following 4 days. Every set of data is an average over the 6 wells.
3. Results
3.1. Tissue expression pattern of BNIPL
The tissue expression pattern of BNIPL (accession no.
AF193056) was investigated by hybridizing its cDNA probe
to a multiple-tissue Northern blot. A transcript of approxi-
mately 2.4 kb was observed in human placenta and lung,
shown in Fig. 1. The expression of BNIPL was investigated
in various cell lines, including NVI-H446 (human small cell
lung cancer), SMMC-7721 (human epithelial-like liver cancer)
and BEL-7402 (human epithelial-like hepatoma). The expres-
sion levels in the three cancer cell lines have no detectable
di¡erences (data not shown).
3.2. Identi¢cation of BNIPL-interacting proteins through yeast
two-hybrid screening
To identify proteins binding to BNIPL, we screened a hu-
man lung cDNA library in a yeast two-hybrid assay using
BNIPL as the bait. A screen of approximately 1.5U106 yeast
transformants yielded 33 positive colonies that grew on the
selective medium and expressed reporter genes. Mating tests
were conducted to pluck the speci¢c interactions. Sequence
analysis in GenBank database revealed that 16 of the 33
clones encoded 10 proteins with known function and two
proteins with unknown function (data not shown). Among
all the positive colonies obtained from yeast two-hybrid
screening, MIF and GFER (augmenter of liver regeneration)
appeared most frequently. In addition, the obtained positive
clones have the entire coding sequences in correct open read-
ing frames.
3.3. BNIPL speci¢cally binds to MIF or GFER
A GST pull-down assay in vitro was carried out to verify
the interactions observed in the yeast two-hybrid screening.
MIF and GFER were fused to GST and expressed in E. coli
strain BL21 with the molecular weight of about 43 and 45
kDa, respectively. The fusion partner GST was also expressed
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Fig. 1. Expression patterns of BNIPL mRNA in di¡erent human
normal tissues. The labeled BNIPL cDNA as a probe hybridized
with a multiple-tissue Northern blot (Clontech) containing 2 Wg
poly(A) RNA from di¡erent human tissues in each lane.
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in the strain BL21 with the molecular weight of 29 kDa as a
control for the speci¢city of the bindings (Fig. 2A). The bac-
terial expressed GST^MIF and GST^GFER conjugated to
glutathione^Sepharose beads were incubated with HA-tagged
BNIPL translated in vitro, respectively. The HA^BNIPL pro-
tein appeared as a 35 kDa band in translated mixture. After
stringently washing, the bound proteins were eluted by elution
bu¡er. The complexes were analyzed by SDS^PAGE and
Western blotting using anti-HA antibody. BNIPL was de-
tected to exist on immunoblot when incubated with two
GST fusion proteins, respectively, but not with GST alone
(Fig. 2B). The GST pull-down assay shows that BNIPL spe-
ci¢cally interacts with MIF and GFER, respectively.
The co-immunoprecipitation approach was used to con¢rm
the interactions in mammalian cells. COS-7 cells were cotrans-
fected with HA-tagged BNIPL and Myc-tagged MIF and
GFER, respectively. pCMV-HA2 and pCMV-Myc vectors
were used as control. The HA-tagged BNIPL was about 35
kDa. The Myc-tagged fusion proteins were about 16 and 18
kDa, respectively (Fig. 2C). Anti-HA antibody and protein
A/G-agarose were added into the cell lysates so as to precip-
itate HA-tagged BNIPL. Two Myc-tagged proteins were de-
tected in the precipitate by Western blotting using anti-Myc
antibody (Fig. 2D). Since the anti-HA antibody and anti-Myc
antibody were both monoclonal antibodies, we also detected
the heavy chain and light chain of mouse IgG besides the
Myc-tagged protein. Both the results of in vitro and in vivo
binding assays are in agreement with those of the yeast two-
hybrid assay.
Both MIF and GFER are cytokines generated by immune
or non-immune cells. They are distributed in both intercellular
and intracellular spaces in vivo. The subcellular localizations
of overexpressed MIF and GFER in COS-7 showed that both
the proteins localized in the cytoplasm, which was consistent
with the subcellular localization of BNIPL [11]. Also, this
suggests that the interactions between BNIPL and MIF or
GFER could be in the cytoplasm.
3.4. The overexpression of BNIPL inhibits the growth of
BEL-7402 cells
The results of yeast two-hybrid screening indicate that
BNIPL may be involved in cell growth. To determine the
e¡ects of BNIPL on the cell proliferation, the colony-forming
e⁄ciency and the growth curve of BNIPL-transfected BEL-
7402 cells were measured using p53 as a positive control. The
overexpression of BNIPL in BEL-7402 cells not only reduced
- 83
- 47.5
- 32.5
- 62
M(kDa)
- 32.5
(kDa)
WB anti-HA
Lysates
HA2-BNIPL
GST-MIF
GST-GFER
GST
HA2-BNIPL
Myc-MIF
Myc-GFER
WB anti-HA WB anti-Myc
(kDa)
- 62 -
- 47.5 -
- 32.5 -
- 16.5 -
- 25 -
+         +
-          +
+         -
+         +
-          +
+         -
+         +
+         -
-          +
-          -
+        +
-         -
-         -
+        -
WB anti-Myc
HA2-BNIPL
Myc-MIF
Myc-GFER
+           +
-            +
+           - (kDa)
- 62
- 47.5
- 32.5
- 25
- 16.5
HC -
LC -
CO-IP anti-HA
G
S
T
-M
IF
G
S
T
-G
F
E
R
G
S
T
A
B
C
D
6
Fig. 2. Validation of binding of BNIPL with MIF or GFER.
A: Fusion proteins of GST-MIF, GST-GFER and GST were ex-
pressed in E. coli BL21, respectively. After puri¢cation using gluta-
thione^Sepharose 4B beads, the expressed fusion proteins were ana-
lyzed by SDS^PAGE and stained by Coomassie. B: The interaction
of BNIPL with MIF or GFER was analyzed by GST pull-down as-
say in vitro. GST fusion proteins immobilized on glutathione^Se-
pharose 4B beads were incubated with HA2^BNIPL translated in
vitro. Interacting proteins were immunoblotted with rabbit anti-HA
primary antibody. BNIPL binds speci¢cally to MIF and GFER, but
not to GST alone. The translation product of BNIPL in vitro was
used as a control. C: Expressions of HA^BNIPL and Myc^MIF or
Myc^GFER in co-transfected COS-7 were analyzed by Western
blotting with mouse anti-HA or anti-Myc primary antibody. D: The
speci¢city of interactions between BNIPL and MIF or GFER was
con¢rmed by co-immunoprecipitation in vivo. Cell lysates from
COS-7 cells co-transfected with HA^BNIPL and Myc^MIF or
Myc^GFER were immunoprecipitated using mouse anti-HA anti-
body. The precipitated proteins were eluted from the protein A/G
PLUS agarose with protein loading bu¡er, and separated by SDS^
PAGE and immunoblotted with mouse anti-Myc primary antibody.
HC and LC represent the heavy chain and light chain of the mouse
IgG.
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the numbers of colonies (Fig. 3) but also inhibited the cell
growth speed. The growth rate of the BEL-7402 cells trans-
fected with BNIPL was reduced by about 30% in contrast to
the reduction of 80% by p53 (Fig. 4). The two results clearly
indicate that the transfection of the pcDNA4-HisMax plasmid
containing BNIPL into human BEL-7402 cells is able to sup-
press the cell growth.
4. Discussion
The yeast two-hybrid system has been a potent tool for
identifying binding partners of protein of interest to study
its potential role in biological activities in vivo. We isolated
two proteins interacting with BNIPL, MIF, a famous pleio-
tropic protein in in£ammatory and immune responses, and
GFER. The bona ¢de interactions were further con¢rmed in
vitro and in vivo.
One partner of BNIPL, MIF, was one of the earliest dis-
covered cytokines four decades ago [12,13]. MIF is identi¢ed
as an integral regulator not only of the in£ammatory and
immune response [14], but also in growth factor-dependent
cell proliferation, cell cycle, angiogenesis and tumorigenesis
[15]. The BNIPL^MIF interaction may occur following up-
take of MIF into target cells by non-receptor-mediated path-
way, which is one of the three hypothetic independent signal
mechanisms for MIF [16]. The inhibition of secreted MIF by
anti-MIF antibody prevents cell growth during serum-induced
cell cycle progression [17]. Other studies also suggest that in-
creased cytosolic MIF expression in tumors is related to the
proliferative properties of tumor cells [16]. The interaction
between BNIPL and MIF suggested that BNIPL would be
involved in governing cell proliferation, the known biological
activities of MIF. Our experiment showed the overexpression
of BNIPL in BEL-7402 cells suppresses cell growth. This sug-
gested that BNIPL could inhibit MIF-mediated tumor cells
proliferation.
Another BNIPL-interacting protein, GFER, acts as an aug-
menter of liver regeneration. The interaction between BNIPL
and GFER also hints that BNIPL functions in cell prolifer-
ation. GFER triggers liver regeneration by activation of in-
active transcription factors that pre-exist in the liver [18]. The
binding of BNIPL with GFER could a¡ect the function of the
endogenous growth factor and therefore inhibit the growth of
liver cells. The expression of BNIPL was detected in two cell
lines but not normal liver tissues. The interaction with GFER
and the speci¢c expression pattern suggest that expression of
BNIPL may respond to hepatectomy or toxic damage.
The bindings of BNIPL with two endogenous cytokines,
MIF and GFER, indicated that BNIPL is functional in e⁄-
cient regulation of cell proliferation. According to bioinfor-
matics analysis, it should be noted that BNIPL has an apo-
ptosis-inducing BCH domain and several biochemical and
morphological assays also indicate that BNIPL could induce
extensive morphological changes and cell death [9^11]. How-
ever, BNIPL-induced apoptosis did not directly involve in the
known caspases and the Bcl-2/Bcl-xL inhibition [11]. BNIPL
could induce apoptosis by itself. The interactions between
BNIPL and MIF or GFER suggest that BNIPL would be
involved in regulation of cell proliferation mediated by the
two cytokines, while MIF and GFER could also take part
in the apoptosis induced by BNIPL. The cell proliferation
and apoptosis are two closely associated and regulated phys-
iological activities [5]. Cells of damaged tissues have to be
confronted with only one choice of survival or death. For
our current best understanding, the interactions of BNIPL
with the two proteins would provide a mechanism for main-
taining in vivo homeostasis between cell proliferation and ap-
optosis.
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